The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico

  Although the diagnostic techniques of medical biotechnology are being applied in Mexico, there is still a significant percentage of people who do not have access to health services, a result of the country's economic inequality. This article aims to present the impact in Mexico of se...

Mô tả đầy đủ

Đã lưu trong:
Chi tiết về thư mục
Tác giả chính: Martínez-González, Sonia -Mirén (author)
Tác giả khác: Martínez Rodríguez, Maria Concepción (author)
Định dạng: article
Ngôn ngữ:spa
Được phát hành: 2021
Những chủ đề:
Truy cập trực tuyến:https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
_version_ 1863522991546040320
author Martínez-González, Sonia -Mirén
author2 Martínez Rodríguez, Maria Concepción
author2_role author
author_facet Martínez-González, Sonia -Mirén
Martínez Rodríguez, Maria Concepción
author_role author
collection Revista Letras Verdes
dc.creator.none.fl_str_mv Martínez-González, Sonia -Mirén
Martínez Rodríguez, Maria Concepción
dc.date.none.fl_str_mv 2021-09-30
dc.format.none.fl_str_mv application/pdf
application/xml
dc.identifier.none.fl_str_mv https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064
10.17141/letrasverdes.30.2021.5064
dc.language.none.fl_str_mv spa
dc.publisher.none.fl_str_mv FLACSO Ecuador
dc.relation.none.fl_str_mv https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064/3890
https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064/3975
dc.rights.none.fl_str_mv Derechos de autor 2021 Sonia -Mirén Martínez-González, Maria Concepción Martínez Rodríguez
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv Letras Verdes. Revista Latinoamericana de Estudios Socioambientales; No. 30 (2021): Letras Verdes (Septiembre-Febrero); 33-50
Letras Verdes. Revista Latinoamericana de Estudios Socioambientales; Núm. 30 (2021): Letras Verdes (Septiembre-Febrero); 33-50
1390-6631
10.17141/letrasverdes.30.2021
reponame:Revista Letras Verdes
instname:Facultad Latinoamericana de Ciencias Sociales
instacron:FLACSO
dc.subject.none.fl_str_mv biotecnología
diagnóstico
biomarcadores
PCR
ELISA
Anticuerpos
México
Biotechnology, diagnosis, biomarkers, PCR, ELISA, antibodies, Mexico
Biotechnology
diagnosis
biomarkers
PCR
ELISA
Antibodies
Mexico
dc.title.none.fl_str_mv The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
La aplicación de la biotecnología en el diagnóstico de enfermedades de importancia en salud pública en México
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
description   Although the diagnostic techniques of medical biotechnology are being applied in Mexico, there is still a significant percentage of people who do not have access to health services, a result of the country's economic inequality. This article aims to present the impact in Mexico of several diseases (COVID-19, acute diarrheal disease, cervical cancer, breast cancer, leishmaniasis, acute kidney injury and neurocysticercosis), the strategies implemented in their diagnosis and control, as well as perspectives of novel diagnostic tests. The article was conducted through a review of online documents from the Mexican government and scientific articles that study the implementation and characteristics of biotechnological tools for disease diagnosis. In the case of COVID-19, the availability of accurate and rapid procedures for its diagnosis has proven to be of vital importance in the control of this disease, as well as in the understanding of infection and immunity processes. In the case of acute diarrheal disease resulting from rotavirus infection, the high morbidity and mortality of diseases cannot be completely controlled until the quality of life of the population is improved. The tools of biotechnology in diagnostics applied through public programs to vulnerable populations provide a way to close the health gap between developed and developing areas. Even so, it must be considered that the amount of resources they use is still high.
eu_rights_str_mv openAccess
format article
id REVLETRASV_472708bd5aa2e2f581a890970c0e59ad
identifier_str_mv 10.17141/letrasverdes.30.2021.5064
instacron_str FLACSO
institution FLACSO
instname_str Facultad Latinoamericana de Ciencias Sociales
language spa
network_acronym_str REVLETRASV
network_name_str Revista Letras Verdes
oai_identifier_str oai:revistas.flacsoandes.edu.ec:article/5064
publishDate 2021
publisher.none.fl_str_mv FLACSO Ecuador
reponame_str Revista Letras Verdes
repository.mail.fl_str_mv .
repository.name.fl_str_mv Revista Letras Verdes - Facultad Latinoamericana de Ciencias Sociales
repository_id_str 0
rights_invalid_str_mv Derechos de autor 2021 Sonia -Mirén Martínez-González, Maria Concepción Martínez Rodríguez
spelling The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in MexicoLa aplicación de la biotecnología en el diagnóstico de enfermedades de importancia en salud pública en MéxicoMartínez-González, Sonia -MirénMartínez Rodríguez, Maria ConcepciónbiotecnologíadiagnósticobiomarcadoresPCRELISAAnticuerposMéxicoBiotechnology, diagnosis, biomarkers, PCR, ELISA, antibodies, MexicoBiotechnologydiagnosisbiomarkersPCRELISAAntibodiesMexico  Although the diagnostic techniques of medical biotechnology are being applied in Mexico, there is still a significant percentage of people who do not have access to health services, a result of the country's economic inequality. This article aims to present the impact in Mexico of several diseases (COVID-19, acute diarrheal disease, cervical cancer, breast cancer, leishmaniasis, acute kidney injury and neurocysticercosis), the strategies implemented in their diagnosis and control, as well as perspectives of novel diagnostic tests. The article was conducted through a review of online documents from the Mexican government and scientific articles that study the implementation and characteristics of biotechnological tools for disease diagnosis. In the case of COVID-19, the availability of accurate and rapid procedures for its diagnosis has proven to be of vital importance in the control of this disease, as well as in the understanding of infection and immunity processes. In the case of acute diarrheal disease resulting from rotavirus infection, the high morbidity and mortality of diseases cannot be completely controlled until the quality of life of the population is improved. The tools of biotechnology in diagnostics applied through public programs to vulnerable populations provide a way to close the health gap between developed and developing areas. Even so, it must be considered that the amount of resources they use is still high.Aunque las últimas técnicas de diagnóstico de la biotecnología médica son aplicadas en México, existe aún un porcentaje importante de personas que no tienen acceso a servicios de salud, resultado de la desigualdad económica en el país. Este artículo tiene como objetivo presentar el impacto en México de diversas enfermedades (COVID-19, enfermedad diarreica aguda, cáncer cervicouterino, cáncer de mama, leishmaniasis, lesiones renales agudas y neurocisticercosis), las estrategias implementadas en su diagnóstico y control, así como las perspectivas de pruebas de diagnóstico novedosas. El artículo se realizó a través de una revisión de documentos en línea del Gobierno mexicano y de artículos científicos que estudian la implementación y las características de las herramientas biotecnológicas para el diagnóstico de enfermedades. En el caso de la COVID-19, la disponibilidad de procedimientos certeros y rápidos para su diagnóstico ha demostrado ser de vital importancia en el control de la enfermedad, así como en el entendimiento de la infección y los procesos de inmunidad. En el caso de la enfermedad diarreica aguda derivada de la infección por rotavirus, la elevada morbilidad y mortalidad de enfermedades no puede ser completamente controlada hasta que mejore la calidad de vida de la población. Las herramientas de la biotecnología para el diagnóstico, aplicadas por medio de programas públicos dirigidos a la población vulnerable, proporcionan una forma de cerrar la brecha de salud entre zonas desarrolladas y en vías de desarrollo. Aun así, se debe considerar que la cantidad de recursos que se utilizan sigue siendo elevada.   Abstract Although the diagnostic techniques of medical biotechnology are being applied in Mexico, there is still a significant percentage of people who do not have access to health services, a result of the country's economic inequality. This article aims to present the impact in Mexico of several diseases (COVID-19, acute diarrheal disease, cervical cancer, breast cancer, leishmaniasis, acute kidney injury and neurocysticercosis), the strategies implemented in their diagnosis and control, as well as perspectives of novel diagnostic tests. The article was conducted through a review of online documents from the Mexican government and scientific articles that study the implementation and characteristics of biotechnological tools for disease diagnosis. In the case of COVID-19, the availability of accurate and rapid procedures for its diagnosis has proven to be of vital importance in the control of this disease, as well as in the understanding of infection and immunity processes. In the case of acute diarrheal disease resulting from rotavirus infection, the high morbidity and mortality of diseases cannot be completely controlled until the quality of life of the population is improved. The tools of biotechnology in diagnostics applied through public programs to vulnerable populations provide a way to close the health gap between developed and developing areas. Even so, it must be considered that the amount of resources they use is still high.FLACSO Ecuador2021-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://revistas.flacsoandes.edu.ec/letrasverdes/article/view/506410.17141/letrasverdes.30.2021.5064Letras Verdes. Revista Latinoamericana de Estudios Socioambientales; No. 30 (2021): Letras Verdes (Septiembre-Febrero); 33-50Letras Verdes. Revista Latinoamericana de Estudios Socioambientales; Núm. 30 (2021): Letras Verdes (Septiembre-Febrero); 33-501390-663110.17141/letrasverdes.30.2021reponame:Revista Letras Verdesinstname:Facultad Latinoamericana de Ciencias Socialesinstacron:FLACSOspahttps://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064/3890https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064/3975Derechos de autor 2021 Sonia -Mirén Martínez-González, Maria Concepción Martínez Rodríguezinfo:eu-repo/semantics/openAccess2021-12-09T00:30:49Zoai:revistas.flacsoandes.edu.ec:article/5064Institucionalhttps://revistas.flacsoandes.edu.ec/letrasverdesUniversidad privadahttps://www.flacso.edu.ec..Ecuador.1390-66311390-6631opendoar:02021-12-09T00:30:49Revista Letras Verdes - Facultad Latinoamericana de Ciencias Socialesfalse
spellingShingle The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
Martínez-González, Sonia -Mirén
biotecnología
diagnóstico
biomarcadores
PCR
ELISA
Anticuerpos
México
Biotechnology, diagnosis, biomarkers, PCR, ELISA, antibodies, Mexico
Biotechnology
diagnosis
biomarkers
PCR
ELISA
Antibodies
Mexico
status_str publishedVersion
title The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
title_full The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
title_fullStr The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
title_full_unstemmed The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
title_short The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
title_sort The Application of Biotechnology in the Diagnosis of Diseases of Public Health Importance in Mexico
topic biotecnología
diagnóstico
biomarcadores
PCR
ELISA
Anticuerpos
México
Biotechnology, diagnosis, biomarkers, PCR, ELISA, antibodies, Mexico
Biotechnology
diagnosis
biomarkers
PCR
ELISA
Antibodies
Mexico
url https://revistas.flacsoandes.edu.ec/letrasverdes/article/view/5064